Yi C-X, Tschöp MH. Brain-gut-adipose tissue communication pathways at a glance. Dis Models Mech 2012; 5: 583-587.[DOI: 10.1242/dmm.009902]
Hassanzadeh P. Tissue engineering and growth factors: updated evidence. Biomed Rev 2012; 23: 19-35. [DOI: http://dx.doi.org/10.14748/bmr.v23.26]
Triaca V. Homage to Rita Levi-Montalcini. Molecular mechanisms of Alzheimer`s disease: NGF modulation of APP processing. Adipobiology 2013; 5: 7-18. [DOI: 10.14748/ adipo.v5.292]
Yanev S, Aloe L, Fiore M, Chaldakov GN. Neurotrophic and metabotrophic potential of nerve growth factor and brainderived neurotrophic factor: Linking cardiometabolic and neuropsychiatric diseases. World J Pharmacol 2013; 2: 92- 99. [DOI: 10.5497/wjp.v2.i4.92]
O`Neill C, Kiely AP, Coakley MF, Manning S, Long-Smith CM. Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer`s disease. Biochem Soc Trans 2012; 40: 721-727. [DOI: 10.1042/BST20120080]
Chaldakov GN, Stankulov IS, Hristova MG, Ghenev PI. Adipobiology of disease: adipokines and adipokine-targeted pharmacology. Curr Pharm Des 2003; 9: 1023-1031. [DOI: 10.2174/1381612033455152]
Renes J, Mariman E. Application of proteomics technology in adipocyte biology. Mol Biosyst 2013; 9: 1076-1091. [DOI: 10.1039/c3mb25596d]
Kiliaan AJ, Arnoldussen IA, Gustafson DR. Adipokines: a link between obesity and dementia? Lancet Neurol 2014; 13: 913-923. [DOI: 10.1016/S1474-4422(14)70085-7]
Wedrychowicz A, Zajac A, Pilecki M, Koscielniak B, Tomasik PJ. Peptides from adipose tissue in mental disorders. World J Psychiatry 2014; 4: 103-111. [DOI: 10.5498/wjp. v4.i4.103]
Beumer W, Drexhage RC, De WH, Versnel MA, Drexhage HA, Cohen D. Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology 2012; 37: 1901-1911. [DOI: 10.1016/j. psyneuen.2012.04.001]
Sornelli F, Fiore M, Chaldakov GN, Aloe L. Adipose tissuederived nerve growth factor and brain-derived neurotrophic factor: results from experimental stress and diabetes. Gen Physiol Biophys 2009; 28: 179-183. [DOI: PMID: 19893098]
Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 1977; 133: 358-366. [DOI: 00068993(77)90772-7]
Brennan AM, Fargnoli JL, Williams CJ, Li T, Willett W, Kawachi I, et al. Phobic anxiety is associated with higher serum concentrations of adipokines and cytokines in women with diabetes. Diabetes Care 2009; 32: 926-931. [DOI: 10.2337/dc08-1979]
Warren MW, Hynan LS, Weiner MF. Lipids and adipokines as risk factors for Alzheimer`s disease. J Alzheimers.Dis. 2012; 29: 151-157. [DOI: 10.3233/JAD-2012-111385]
Song J, Lee JE. Adiponectin as a new paradigm for approaching Alzheimer`s disease. Anat Cell Biol 2013; 46: 229- 234. [DOI: 10.5115/acb.2013.46.4.229]
Signore AP, Zhang F, Weng Z, Gao YQ, Chen J. Leptin neuroprotection in the central nervous system: Mechanisms and therapeutic potentials. J Neurochem 2008; 106: 1977- 1990. [DOI: 10.1111/j.1471-4159.2008.05457.x]
Tezapsidis N, Johnston JM, Smith MA, Ashford JW, Casadesus G, Robakis NK, et al. Leptin: a novel therapeutic strategy for Alzheimer`s disease. J Alzheimers Dis 2009;16: 731-740. [DOI: 10.3233/JAD-2009-1021]
Greco SJ, Sarkar S, Casadesus G, Zhu X, Smith MA, Ashford JW, et al. Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells. Neurosci Lett 2009; 455: 191-194. [DOI: 10.1016/j. neulet.2009.03.066]
Greco SJ, Sarkar S, Johnston JM, Tezapsidis N. Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochem Biophys Res Commun 2009; 380: 98-104. [DOI: 10.1016/j.bbrc.2009.01.041]
Ghasemi M, Zendehbad B, Zabihi H, Hosseini M, Hadjzadeh MA, Hayatdavoudi P. Beneficial effect of leptin on spatial learning and memory in streptozotocin induced diabetic rats. Balkan Med J [DOI: 10.5152/ balkanmedj.2015.15084]
Greco SJ, Bryan KJ, Sarkar S, Zhu X, Smith MA, Ashford JW, et al. Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer`s disease. J Alzheimers Dis 2010; 19: 1155-1167. [DOI: 10.3233/JAD- 2010-1308]
Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, et al. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 2009; 302: 2565-2572. [DOI: 10.1001/jama.2009.1836]
Lu XY. The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol 2007; 7: 648-652. [DOI: 10.1016/j.coph.2007.10.010]
Carro EM. Therapeutic approaches of leptin in Alzheimer`s disease. Recent Pat CNS Drug Discov 2009; 4: 200-208. [DOI: 10.2174/157488980903150306103527]
Lee YH, Tharp WG, Maple RL, Nair S, Permana PA, Pratley RE. Amyloid precursor protein expression is upregulated in adipocytes in obesity. Obesity (Silver Spring) 2008; 16: 1493- 1500. [DOI: 10.1038/oby.2008.267]
Wan Z, Mah D, Simtchouk S, Kluftinger A, Little JP. Role of amyloid beta in the induction of lipolysis and secretion of adipokines from human adipose tissue. Adipocyte 2015; 4: 212-216. [DOI: 10.4161/21623945.2014.985020]
Truran S, Franco DA, Roher AE, Beach TG, Burciu C, Serrano G, et al. Adipose and leptomeningeal arteriole endothelial dysfunction induced by beta-amyloid peptide: a practical human model to study Alzheimer`s disease vasculopathy. J Neurosci Methods 2014; 235: 123-129. [DOI: 10.1016/j.jneumeth. 2014.06.014]
Puig KL, Combs CK. Expression and function of APP and its metabolites outside the central nervous system. Exp Gerontol 2013; 48: 608-611. [DOI: 10.1016/j.exger.2012.07.009]
Puig KL, Floden AM, Adhikari R, Golovko MY, Combs CK. Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity. PLoS One 2012; 7: e30378. [DOI: 10.1371/journal.pone.0030378]
Freeman LR, Zhang L, Dasuri K, Fernandez-Kim SO, Bruce-Keller AJ, Keller JN. Mutant amyloid precursor protein differentially alters adipose biology under obesogenic and non-obesogenic conditions. PLoS.One. 2012; 7: e43193. [DOI: 10.1371/journal.pone.0043193]
Wang X, Yu S, Hu JP, Wang CY, Wang Y, Liu HX, et al. Streptozotocin- induced diabetes increases amyloid plaque deposition in AD transgenic mice through modulating AGEs/ RAGE/NF-B pathway. Int J Neurosci 2014; 124: 601-608. [DOI: 10.3109/00207454.2013.866110]
Shingo AS, Kanabayashi T, Kito S, Murase T. Intracerebroventricular administration of an insulin analogue recovers STZ-induced cognitive decline in rats. Behav Brain Res 2013; 241: 105-111. [DOI: 10.1016/j.bbr.2012.12.005]
Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer`s disease. J Alzheimers Dis 2006; 9: 13-33. [DOI: PMID: 16627931]
Sposato V, Manni L, Chaldakov GN, Aloe L. Streptozotocininduced diabetes is associated with changes in NGF levels in pancreas and brain. Arch Ital.Biol 2007; 145: 87-97. [DOI: 10.3109/00207454.2013.866110]
de la Monte SM, Wands JR. Alzheimer`s disease is type 3 diabetes - evidence reviewed. J Diab Sci Technol 2008; 2: 1101-1113. [DOI: PMC2769828]
Sridhar GR, Lakshmi G, Nagamani G. Emerging links between type 2 diabetes and Alzheimer`s disease. World J Diabetes 2015 ; 6. [DOI: 10.4239/wjd.v6.i5.1]
Dar A, Sheikh A, Ganie A, Ali R, Singh R, Gan SH, et al. Molecular linkages between diabetes and Alzheimer`s disease: Current scenario and future prospects. CNS Neurol Disord - Drug Targets 2014; 13: 290-298. [DOI: 10.2174/18715273113126660135]
Rios JA, Cisternas P, Arrese M, Barja S, Inestrosa NC. Is Alzheimer`s disease related to metabolic syndrome? A Wnt signaling conundrum. Prog Neurobiol 2014; 121: 125-146. [DOI: 10.1016/j.pneurobio.2014.07.004]
Jackson HM, Soto I, Graham LC, Carter GW, Howell GR. Clustering of transcriptional profiles identifies changes to insulin signaling as an early event in a mouse model of Alzheimer`s disease. BMC.Genomics 2013; 14: 831. [DOI: 10.1186/1471-2164-14-831]
Luchsinger JA, Mayeux R. Adiposity and Alzheimer`s disease. Curr Alzheimer Res 2007; 4: 127-134. [DOI: 10.2174/156720507780362100 ]
Naderali EK, Ratcliffe SH, Dale MC. Obesity and Alzheimer`s disease: a link between body weight and cognitive function in old age. Am.J Alzheimers Dis Other Demen 2009; 24: 445-449. [DOI: 10.1177/1533317509348208]
de la Monte SM. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer`s disease. Curr Alzheimer Res 2012; 9: 35-66. [DOI: 10.2174/156720512799015037]
Hildreth KL, Van Pelt RE, Schwartz RS. Obesity, insulin resistance, and Alzheimer`s disease. Obesity (Silver.Spring) 2012; 20: 1549-1557. [DOI: 10.1038/oby.2012.19]
Arnoldussen IA, Kiliaan AJ, Gustafson DR. Obesity and dementia: adipokines interact with the brain. Eur Neuropsychopharmacol 2014; 24: 1982-1999. [DOI: 10.1016/j.euroneuro. 2014.03.002]
Strittmatter WJ. Alzheimer`s disease: the new promise. J Clin Invest 2012; 122: 1191. [DOI: 10.1172/JCI62745]
Sebastiao I, Candeias E, Santos MS, de Oliveira CR, Moreira PI, Duarte AI. Insulin as a bridge between type 2 diabetes and Alzheimer disease - How anti-diabetics could be a solution for dementia. Front Endocrinol (Lausanne) 2014; 5: 110. [DOI: 10.3389/fendo.2014.00110]
Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens Ph. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5: 64-74. [DOI: 10.1016/S1474- 4422(05)70284-2]
Sima AA, Li ZG. Diabetes and Alzheimer`s disease - is there a connection? Rev Diabet Stud 2006; 3: 161-168. [DOI: 10.1900/RDS.2006.3.161]
Li L, Holscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 2007; 56: 384-402. [DOI: 10.1016/j.brainresrev.2007.09.001]
Sjogren M, Blennow K. The link between cholesterol and Alzheimer`s disease. World J Biol Psychiatry 2005; 6: 85-97.
Sun MK, Alkon DL. Links between Alzheimer`s disease and diabetes. Drugs Today (Barc) 2006; 42: 481-489. [DOI: 10.1358/dot.2006.42.7.973588]
Giordano V, Peluso G, Iannuccelli M, Benatti P, Nicolai R, Calvani M. Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer`s dementia. Neurochem Res 2007; 32: 555-567. [DOI: 10.1007/s11064-006- 9125-8]
Manning S. Diabetes and dementia: a common link or coincidental coexistence. Biomed Rev 2007; 18: 59-64. [DOI: http://dx.doi.org/10.14748/bmr.v18.68]
Erol A. An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer`s disease. J Alzheimers Dis 2008;13:241-253.
Hao K, Di Narzo AF, Ho L, Luo W, Li S, Chen R, et al. Shared genetic etiology underlying Alzheimer`s disease and type 2 diabetes. Mol Aspects Med 2015; 43-44: 66-76. [DOI: 10.1016/j.mam.2015.06.006]
Shingo AS, Mervis RF, Kanabayashi T, Kito S, Murase T. The dendrites of granule cell layer neurons are the primary injury sites in the `Brain Diabetes` rat. Behav Brain Res 2015; 280: 78-83. [DOI: 10.1016/j.bbr.2014.11.041]
Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, et al. Metabolic-cognitive syndrome: a crosstalk between metabolic syndrome and Alzheimer`s disease. Ageing Res Rev 2010; 9: 399-417. [DOI: 10.1016/j. arr.2010.04.007]
Chen Y, Zhou K, Wang R, Liu Y, Kwak YD, Ma T, et al. Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer`s amyloid peptides via up-regulating BACE1 transcription. Proc.Natl.Acad.Sci U.S.A 2009; 106: 3907-3912. [DOI: 10.1073/pnas.0807991106]
Moore EM, Mander AG, Ames D, Kotowicz MA, Carne RP, Brodaty H, et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 2013; 36: 2981-2987. [DOI: 10.2337/ dc13-0229]
Katsuda T, Tsuchiya R, Koska N, Yoshioka Y, Takagaki K, Oki K, et al. Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep 2013; 3, Article number: 1197. [DOI: 10.1038/ srep01197]
Chaldakov GN, Aloe L, Tonchev AB, Chervenkov T, Fiore M, Zhelezov M. Neuro-adipose interactions (biactome). Implication in cardiometabolic disease. Proc Rom Acad Series B 2014; 16:133-141.
Chaldakov GN, Fiore M, Ghenev PI, Beltowski J, Rancic G, Tuncel N, et al. Triactome: neuro-immune-adipose interactions. Implication in vascular biology. Front Immunol 2014; 5: 130. [DOI: 10.3389/fimmu.2014.00130]
Chaldakov GN, Fiore M, Tonchev AB, Dimitrov D, Pancheva R, Rancic G, Aloe L. Homo obesus: a metabotrophindeficient species. Pharmacology and nutrition insight. Curr Pharm Des 2007; 13: 2176-2179.
Chaldakov GN, Tonchev AB, Aloe L. NGF and BDNF: from nerves to adipose tissue, from neurokines to metabokines. Riv Psichiatr 2009;44:79-87.
Email this article (Login required) 
